Recall Register

Device recall: ExacTrac versions 6.5 through 6.5 intended to be used to place patients at an accurately defined point within the…

Class II FDA enforcement event 79266. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

The usage of workflows that deviate from the recommended specifications in the User manual for ExacTrac Patient Positioning System (versions 6.0, 6.1, 6.2, 6.5) with Auxiliary Device Interface (ADI) and Varian Clinac or Varian TrueBeam, which may result in misinterpretation of beam authorization via ADI.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Brainlab AG started this device recall on 14 Feb 2018. The firm address in the FDA record is in Munich. FDA put the recall in Class II. FDA event 79266 has 1 product record. The first FDA enforcement report date is 21 Mar 2018. The record gives the status Terminated, with the termination date 17 May 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

worldwide

Recalling firm

Brainlab AG, Munich, Germany.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 79266: product records
Recall numberProductQuantityClassStatusReport date
Z-1006-2018ExacTrac versions 6.5 through 6.5 intended to be used to place patients at an accurately defined point within the treatment beam of a medical accelerator for stereotactic radiosurgery or radiotherapy procedures, in order to treat lesions, tumors and conditions anywhere in the body when radiation treatment is…587 systemsClass IITerminated21 Mar 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2018
1,074
Share of these events in Class II
92%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
36

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 79266. https://recallregister.com/fda/ii/79266/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: worldwide
What quantity of product is in FDA event 79266?
The FDA record gives this quantity: 587 systems
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2018 have the same class?
92% of the 1,074 device events that started in 2018 are in Class II.